BioCentury
ARTICLE | Company News

Arena, J&J deal

November 8, 2010 8:00 AM UTC

Johnson & Johnson unit Ortho-McNeil-Janssen Pharmaceuticals Inc. will terminate a 2004 deal and return rights to APD597 to Arena. The glucose-dependent insulinotropic (GDI; 19AJ) receptor agonist comp...